NuVasive, Inc. Financials

Market Capitalization $2.33 Billion as of July 1, 2023

Valuations Metrics as of Jan. 25, 2025

Trailing PE	4.44
Forward PE	-2.53
Price to Sales TTM	€0.33
Price to Book MRQ	€0.19
Enterprise to Revenue	8.08
Enterprise to EBITDA	65.72

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2023-12-31
Profit Margin	-57.91%
Operating Margin	11.73%
Return on Assets TTM	0.77%
Return on Equity TTM	-37.26%

Income Statement

Revenue TTM	€47,453,000
Revenue per Share TTM	€7.71
Quarterly Revenue Growth	-38.00%
Gross Profit TTM	€15,578,000
EBITDA	€15,009,000
Net Income to Common TTM	€-27,478,000
Diluted EPS TTM	€-4.15
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	€11,653,000
Total Cash per Share MRQ	€1.62
Total Debt MRQ	€
Total Debt to Equity MRQ	583.37
Current Ratio MRQ	7.75
Book Value per Share MRQ	€9.08

Cash Flow

Operating Cash Flow TTM	€14,850,000
Levered Free Cash Flow TTM	€22,324,750

NUVA Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	8,878,180
Float Shares	3,205,700
Avg 10 Volume	800
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	55.40%
% Held by Institutions	1.20%

Stock Price Summary

Beta	0.25
Fifty Two Week Low	€1.17
Fifty Two Week High	€6.95
Fifty Two Week Change	-295.21%
Day 50 MA	€1.63
Day 200 MA	€2.91

Dividends and Splits

Forward Annual Dividend Rate	€2.01
Forward Annual Dividend Yield	120.13%
Trailing Annual Dividend Rate	€0.50
Trailing Annual Dividend Yield	30.03%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2022-06-24
Last Split Factor
Last Split Date